Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier

Recruiting

Percepta Nasal SwabClinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier

Sponsor:

Veracyte, Inc.

Code:

NCT06426628

Conditions

Pulmonary Nodule, Solitary

Lung Cancer

Eligibility Criteria

Sex: All

Age: 29 - 70+

Healthy Volunteers: Not accepted

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-15. This information was provided to ClinicalTrials.gov by Veracyte, Inc. on 2024-11-13.